Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 21, 2018
Previous Article Next Article

A liver-immune coculture array for predicting systemic drug-induced skin sensitization

Author affiliations


Drug-induced skin sensitization is prevalent worldwide and can trigger life-threatening health conditions, such as Stevens Johnson Syndrome. However, existing in vitro skin models cannot adequately predict the skin sensitization effects of drugs administered into the systemic circulation because dermal inflammation and injury are preceded by conversion of parent drugs into antigenic reactive metabolites in the liver and subsequent activation of the immune system. Here, we demonstrate that recapitulation of these early tandem cellular processes in a compartmentalized liver-immune coculture array is sufficient to predict the skin sensitization potential of systemic drugs. Human progenitor cell (HepaRG)-derived hepatocyte spheroids and U937 myeloid cells, a representative antigen presenting cell (APC), can maintain their respective functions in 2 concentric micro-chambers, which are connected by a diffusion microchannel network. Paradigm drugs that are reported to cause severe cutaneous drug reactions (i.e. carbamazepine, phenytoin and allopurinol) can be metabolized into their reactive metabolites, which diffuse efficiently into the adjoining immune compartment within a 48 hour period. By measuring the extent of U937 activation as indicated by IL8, IL1β and CD86 upregulation upon drug administration, we show that the liver-immune coculture array more consistently and reliably distinguish all 3-paradigm skin sensitizing drugs from a non-skin sensitizer than conventional bulk Transwell coculture. Given its miniaturized format, design simplicity and prediction capability, this novel in vitro system can be readily scaled into a screenable platform to identify the skin sensitization potential of systemically-administered drugs.

Graphical abstract: A liver-immune coculture array for predicting systemic drug-induced skin sensitization

Back to tab navigation

Supplementary files

Publication details

The article was received on 01 Aug 2018, accepted on 21 Sep 2018 and first published on 21 Sep 2018

Article type: Paper
DOI: 10.1039/C8LC00790J
Citation: Lab Chip, 2018,18, 3239-3250

  •   Request permissions

    A liver-immune coculture array for predicting systemic drug-induced skin sensitization

    L. H. Chong, H. Li, I. Wetzel, H. Cho and Y. Toh, Lab Chip, 2018, 18, 3239
    DOI: 10.1039/C8LC00790J

Search articles by author